HDA has published “A Year in Review,” which chronicles the Alliance’s 2019 activities. Highlighted accomplishments include:

With 2020 underway, HDA’s John M. Gray provided perspective on the vital role of pharmaceutical distributors and the Alliance’s policy priorities as part of Chain Drug Review’s annual “Pharmacy Outlook” feature.

In an opinion piece published today in the Capitol Hill newspaper, The Hill, HDA and NACDS called on members of Congress to honor its commitment to protecting patients and the safety of the supply chain by rejecting any proposal that would call for the importation of prescription drugs from foreign markets.